2026 ESC Guidelines for the management of heart failure

ESC Pocket Guidelines

28 Aug 2026
+ 2026-08-28T08:00 2026-08-28T08:00 Europe/Paris 2026 ESC Guidelines for the management of heart failure
Add to calendar 2026-08-28T08:00 2026-08-28T08:00 Europe/Paris 2026 ESC Guidelines for the management of heart failure
cover

Publication Date: August 2026
Chairpersons: Lars Køber and Marianna Adamo

Table of Contents 

  • Introduction
  • Definition, epidemiology, and classifications
    • Definition of HF
    • ClassificationPrevention of HF
  • Prevention of HF
  • Diagnosis of chronic HF
    • Key steps in the diagnosis of chronic HF
    • HF phenotypes based on left ventricular ejection fraction
      • Heart failure with reduced ejection fraction
      • Heart failure with preserved ejection fraction
    • Aetiology and subtypes of HF
  • Management of chronic HF
    • Guideline-directed medical therapy for HF
    • Guideline-directed interventional therapies for chronic HF
      • Implantable cardioverter-defibrillators
      • Cardiac resynchronization therapy
  • Decompensated HF
    • Diagnosis
    • Clinical presentation
    • General management
    • Treatment
  • Decongestion management
  • Temporary mechanical circulatory support
  • Advanced HF
    • Epidemiology, definition, prognosis, and referral
    • Management
      • Pharmacological therapy and kidney replacement therapy
      • Mechanical circulatory support
      • Heart transplantation
  • Cardiovascular comorbidities
    • Arrhythmias and conduction disturbances
    • Chronic coronary syndromes
    • Valvular heart disease
    • Non-cardiovascular comorbidities
    • Obesity
    • Diabetes
    • Chronic Kidney Disease
    • Iron deficiency and anaemia
    • Cancer
    • Lung disease and sleep-disordered breathing
    • Anxiety, depression and frailty
    • Other non-cardiovascular comorbidities
  • Multidisciplinary team management, long-term follow-up, and patient care
    • Exercise training and cardiac rehabilitation
    • Telemonitoring
  • Long-term follow-up
  • Specific conditions
    • Pregnancy and HF
    • Amyloidosis